Table 4 Summary of adverse events.

Loss of erectile function

0

0

0

Decrease of erectile function (temporary)

2

1

0

0.008

Penile oedema

0

0

0

Long-standing haematoma

2

1

1

0.011

Seroma

2

0

0

0.005

Dehiscence

0

0

N/A

No increase in girth

0

N/A

0

Fat loss (>30%)

15

N/A

6

0.059

Fat nodules, fat lumps

1

N/A

1

0.005

Fat migration

1

N/A

0

0.003

Sclerosing lipogranuloma

0

N/A

0

Loss of sensation (mild)

3

0

2

0.001

Fibrosis

0

0

0

Superficial infection

1

0

1

0.005

Deep infection

0

0

0

Paradoxical penile shortening

0

0

N/A

No increase in length

0

0

N/A

Delayed wound healing

3

1

N/A

0.011

Penile deformity

0

0

0

Penile asimmetry

1

N/A

1

0.005

Penile curvature

0

0

N/A

Decreased erection angle (penile instability)

1

1

N/A

0.005

Hypertrophic wound scarring

2

1

N/A

0.008

Keloid

1

0

0

0.003

Scrotalization

0

0

0

Disfiguring advancement of suprapubic hairy skin

2

0

N/A

0.005